Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: ALK 💬 Brigatinib 💬 Brigatinib 1件: 34 💬 💬
2 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: ALK 💬 Crizotinib 💬 Crizotinib 1件: 34 💬 💬
3 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: CD274 💬 Atezolizumab 💬 Atezolizumab 1件: 85 💬 💬
4 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: CD274 💬 Durvalumab 💬 Durvalumab 1件: 85 💬 💬
5 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 3件: CD3D, CD3E, CD3G 💬 Otelixizumab 💬 Otelixizumab 1件: 46 💬 💬
6 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 3件: CD3D, CD3E, CD3G 💬 Visilizumab 💬 Visilizumab 2件: 96, 97 💬 💬
7 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: CD3E 💬 Mosunetuzumab 💬 Mosunetuzumab 1件: 49 💬 💬
8 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: CD4 💬 Zanolimumab 💬 Zanolimumab 1件: 46 💬 💬
9 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: EGFR 💬 Cetuximab 💬 Cetuximab 2件: 51, 86 💬 💬
10 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: EGFR 💬 Erlotinib 💬 Erlotinib 1件: 94 💬 💬
11 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: EGFR 💬 Gefitinib 💬 Gefitinib 1件: 75 💬 💬
12 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬 💬
13 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬 💬
14 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬 💬
15 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: EGFR 💬 Tesevatinib 💬 Tesevatinib 1件: 67 💬 💬
16 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: IFNG 💬 Emapalumab 💬 Emapalumab 3件: 49, 65, 107 💬 💬
17 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: IFNG 💬 Fontolizumab 💬 Fontolizumab 1件: 46 💬 💬
18 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 2件: IFNGR1, IFNGR2 💬 Interferon gamma-1b 💬 Interferon gamma-1b 7件: 18, 65, 85, 228, 299, 301, 326 💬 💬
19 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: JAK1 💬 Abrocitinib 💬 Abrocitinib 1件: 84 💬 💬
20 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: JAK1 💬 Filgotinib 💬 Filgotinib 6件: 46, 53, 96, 97, 222, 271 💬 💬
21 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: JAK1 💬 Itacitinib 💬 Itacitinib 4件: 46, 51, 97, 228 💬 💬
22 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271 💬 💬
23 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 2件: JAK1, JAK2 💬 Baricitinib 💬 Baricitinib 13件:  2 , 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬 💬
24 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 2件: JAK1, JAK2 💬 Peficitinib 💬 Peficitinib 1件: 46 💬 💬
25 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 2件: JAK1, JAK2 💬 Ruxolitinib 💬 Ruxolitinib 3件: 60, 65, 228 💬 💬
26 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 2件: JAK1, JAK2 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬 💬
27 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: LCK 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬 💬
28 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: LCK 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬 💬
29 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬 💬
30 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 2件: MAP2K1, MAP2K2 💬 Cobimetinib 💬 Cobimetinib 1件: 280 💬 💬
31 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 1件: 34 💬 💬
32 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬 💬
33 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 4件:  2 , 34, 279, 280 💬 💬
34 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 4件: MAPK11, MAPK12, MAPK13, MAPK14 💬 Losmapimod 💬 Losmapimod 2件: 113, 222 💬 💬
35 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 4件: MAPK11, MAPK12, MAPK13, MAPK14 💬 Neflamapimod 💬 Neflamapimod 1件:  8  💬 💬
36 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬 💬
37 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 40件:  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬 💬
38 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 1件: 13 💬 💬
39 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: NFKB1 💬 Iguratimod 💬 Iguratimod 5件: 46, 51, 53, 271, 300 💬 💬
40 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: PDCD1 💬 Nivolumab 💬 Nivolumab 12件: 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬 💬
41 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: PDCD1 💬 Pembrolizumab 💬 Pembrolizumab 2件: 25, 285 💬 💬
42 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: PIK3CA 💬 Alpelisib 💬 Alpelisib 1件: 138 💬 💬
43 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 3件: PIK3CA, PIK3CB, PIK3CD 💬 Leniolisib 💬 Leniolisib 2件: 53, 65 💬 💬
44 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: PIK3CD 💬 Parsaclisib 💬 Parsaclisib 3件: 35, 53, 61 💬 💬
45 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Cyclosporine 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬 💬
46 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Pimecrolimus 💬 Pimecrolimus 1件: 160 💬 💬
47 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Tacrolimus 💬 Tacrolimus 34件:  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 💬
48 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Tacrolimus 💬 Tacrolimus 34件:  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 💬
49 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Voclosporin 💬 Voclosporin 2件: 49, 222 💬 💬
50 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: PRKCQ 💬 Sotrastaurin 💬 Sotrastaurin 1件: 97 💬 💬
51 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬 💬
52 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: RELA 💬 Edasalonexent 💬 Edasalonexent 1件: 113 💬 💬
53 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: TLR9 💬 Cobitolimod 💬 Cobitolimod 1件: 97 💬 💬